Nishadil
Signup Signin
Delhi | 25°C (windy)
Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target

Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target
Pioneering the Future: KFSH&RC Unveils Middle East's First Smart Neuroscience Ward for Ultra-Precise Brain Monitoring

Pioneering the Future: KFSH&RC Unveils Middle East's First Smart Neuroscience Ward for Ultra-Precise Brain Monitoring
A New Dawn for Epilepsy Patients: Rapport's Promising Drug Advances to Phase 3 Trials

A New Dawn for Epilepsy Patients: Rapport's Promising Drug Advances to Phase 3 Trials
A New Era of Hope: AIIMS Bhubaneswar Launches State-of-the-Art Centre for Neuromodulation Services

A New Era of Hope: AIIMS Bhubaneswar Launches State-of-the-Art Centre for Neuromodulation Services
Unbreakable Hope: How One Family's Fight Against a Rare Disorder Sparked a Star-Studded Movement

Unbreakable Hope: How One Family's Fight Against a Rare Disorder Sparked a Star-Studded Movement
Load more..